BR9611511A - Derivados de aminoácidos excitatórios - Google Patents

Derivados de aminoácidos excitatórios

Info

Publication number
BR9611511A
BR9611511A BR9611511A BR9611511A BR9611511A BR 9611511 A BR9611511 A BR 9611511A BR 9611511 A BR9611511 A BR 9611511A BR 9611511 A BR9611511 A BR 9611511A BR 9611511 A BR9611511 A BR 9611511A
Authority
BR
Brazil
Prior art keywords
amino acid
acid derivatives
excitatory amino
excitatory
derivatives
Prior art date
Application number
BR9611511A
Other languages
English (en)
Inventor
Steven Marc Massey
James Allen Monn
Matthew John Valli
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9605434.1A external-priority patent/GB9605434D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BR9611511A publication Critical patent/BR9611511A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
BR9611511A 1995-11-16 1996-11-12 Derivados de aminoácidos excitatórios BR9611511A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US686495P 1995-11-16 1995-11-16
GBGB9605434.1A GB9605434D0 (en) 1996-03-15 1996-03-15 Excitatory amino acid derivatives
PCT/US1996/018112 WO1997018199A1 (en) 1995-11-16 1996-11-12 Excitatory amino acid derivatives

Publications (1)

Publication Number Publication Date
BR9611511A true BR9611511A (pt) 1999-05-04

Family

ID=26308935

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611511A BR9611511A (pt) 1995-11-16 1996-11-12 Derivados de aminoácidos excitatórios

Country Status (22)

Country Link
EP (1) EP0774461B1 (pt)
KR (1) KR19990067598A (pt)
CN (1) CN1202167A (pt)
AR (2) AR006748A1 (pt)
AT (1) ATE319685T1 (pt)
AU (1) AU703409B2 (pt)
BR (1) BR9611511A (pt)
CA (1) CA2237910C (pt)
CO (1) CO4770955A1 (pt)
CZ (1) CZ150198A3 (pt)
DE (1) DE69635886T2 (pt)
EA (1) EA001617B1 (pt)
ES (1) ES2258771T3 (pt)
HU (1) HUP9903459A3 (pt)
IL (1) IL124487A (pt)
NO (1) NO982202D0 (pt)
NZ (1) NZ323205A (pt)
PE (1) PE17798A1 (pt)
PL (1) PL326695A1 (pt)
TR (1) TR199800877T2 (pt)
WO (1) WO1997018199A1 (pt)
YU (1) YU60796A (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2275777A1 (en) * 1997-01-29 1998-07-30 Louise Richman Levine Treatment for premenstrual dysphoric disorder
US6825211B1 (en) 1997-07-18 2004-11-30 Georgetown University Bicyclic metabotropic glutamate receptor ligands
US6204292B1 (en) * 1997-07-18 2001-03-20 Georgetown University Bicyclic metabotropic glutamate receptor ligands
DE19801646A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte alpha,beta-annellierte Butyrolactone
DE19801648A1 (de) * 1998-01-17 1999-07-22 Bayer Ag alpha-Substituierte Lactone
DE19801636A1 (de) * 1998-01-17 1999-07-22 Bayer Ag Substituierte bicyclische Lactone
DE19801647A1 (de) * 1998-01-17 1999-07-22 Bayer Ag Substituierte beta,gamma-annellierte Lactone
GB2355982A (en) * 1999-11-03 2001-05-09 Lilly Co Eli Heterocyclic amino acids
TWI315666B (en) * 2002-06-11 2009-10-11 Lilly Co Eli Prodrugs of excitatory amino acids
DK2370377T3 (en) 2008-11-14 2016-01-04 Dsm Fine Chem Austria Gmbh METHOD FOR PRODUCING cyclopropane derivatives
WO2010111080A2 (en) 2009-03-27 2010-09-30 Eli Lilly And Company Optimized treatment of schizophrenia
US8735397B2 (en) 2010-03-29 2014-05-27 Vanderbilt University Method for treating schizophrenia and related diseases
KR101598679B1 (ko) 2011-06-17 2016-02-29 일라이 릴리 앤드 캄파니 mGlu2 수용체 효능제로서의 비시클로(3.1.0)헥산-2,6-디카르복실산 유도체
AR089718A1 (es) 2012-02-01 2014-09-10 Lilly Co Eli AGONISTAS DE mGlu2/3
IL279202B2 (en) 2014-01-21 2023-09-01 Janssen Pharmaceutica Nv Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use
PL3431106T3 (pl) 2014-01-21 2021-06-28 Janssen Pharmaceutica Nv Kombinacje zawierające pozytywne modulatory allosteryczne metabotropowego receptora glutaminergicznego podtypu 2 i ich zastosowanie

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2572842A (en) * 1947-08-05 1951-10-30 Du Pont The n-carboanhydride of 2-amino-4, 6, 6-trimethylheptanoic acid and polymers therefrom
US4536330A (en) * 1982-09-23 1985-08-20 International Flavors & Fragrances Inc. 1-Hydroxymethyl-2-acyl cyclopropane derivatives and esters and cyclic condensation products thereof, organoleptic uses of same and processes for preparing same
PL182285B1 (pl) * 1994-08-12 2001-12-31 Lilly Co Eli Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL
PT776201E (pt) * 1994-08-12 2002-03-28 Lilly Co Eli Composicao e metodo para tratar a ansiedade
EP0776200A4 (en) * 1994-08-12 2001-01-17 Lilly Co Eli AGENT AND METHOD FOR PROTECTING DRUG ADDICTION

Also Published As

Publication number Publication date
DE69635886T2 (de) 2006-10-19
NO982202L (no) 1998-05-14
AR004602A1 (es) 1998-12-16
EP0774461A1 (en) 1997-05-21
CA2237910A1 (en) 1997-05-22
TR199800877T2 (xx) 1998-09-21
CA2237910C (en) 2005-12-27
HUP9903459A2 (hu) 2001-04-28
EA199800377A1 (ru) 1998-10-29
NZ323205A (en) 1999-06-29
IL124487A (en) 2001-01-11
ES2258771T3 (es) 2006-09-01
NO982202D0 (no) 1998-05-14
AU703409B2 (en) 1999-03-25
YU60796A (sh) 1998-12-23
EP0774461B1 (en) 2006-03-08
AU7727996A (en) 1997-06-05
EA001617B1 (ru) 2001-06-25
PL326695A1 (en) 1998-10-26
WO1997018199A1 (en) 1997-05-22
KR19990067598A (ko) 1999-08-25
CZ150198A3 (cs) 1998-10-14
ATE319685T1 (de) 2006-03-15
CN1202167A (zh) 1998-12-16
HUP9903459A3 (en) 2001-08-28
AR006748A1 (es) 1999-09-29
CO4770955A1 (es) 1999-04-30
DE69635886D1 (de) 2006-05-04
PE17798A1 (es) 1998-04-18
IL124487A0 (en) 1998-12-06

Similar Documents

Publication Publication Date Title
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
DK0696577T3 (da) Syntetiske excitatoriske aminosyrer
DE69522717D1 (de) Chinazolinderivate
DE122009000076I1 (de) Chinazolin-derivate
DE69610698T2 (de) Chinazolin-derivate
BR9611834A (pt) Derivados de oximetóxi-3-aril-pirona
BR9605434A (pt) Derivados de purin-6-ona
ATE199150T1 (de) Diphenylmethylenpiperidin-derivate
BR9611511A (pt) Derivados de aminoácidos excitatórios
BR9606814A (pt) Amidas de ácido alcoximinoacético
BR9611509A (pt) Antagonistas de receptores de aminoácidos excitativos
NO950477D0 (no) Aminosyrederivater
DE69606053T2 (de) Modifizierte fluorsulfonsäure
DE69601527D1 (de) Pyrrolylbenzimidazol-Derivate
BR9610239A (pt) Proteínas de fusão-alérgeno-xcd32
ATA100695A (de) Prothrombin-derivate
PT856007E (pt) Derivados de ciclopeptidos
BR9609671A (pt) Amino uracilas substituídas
BR9610597A (pt) Derivados de diarilalcenilamina
ATE202093T1 (de) 4-amino-benzoylguanidin-derivate
DE59610106D1 (de) Fluorbenzylether-Derivate
ATE177102T1 (de) Chromanderivate
BR9603508A (pt) Derivados de alquenil-benzoilguanidina
PT843675E (pt) Derivados de aza-antraciclinona
DE59607055D1 (de) 4-Mercapto-benzoylguanidin-Derivate

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time